Moderna(MRNA) - 2024 Q4 - Earnings Call Presentation

Fourth Quarter & Full Year 2023 Financial Results l 2024 Priorities Stéphane Bancel, CEO 3 5 © 2024 Moderna, Inc. All rights reserved. Sales at low end of framework at $6.1B, excluding the recognition of $0.6B in deferred revenue related to Gavi • Competitor contract prevented us from competing in the EU in 2H • Strong performance in Israel, Switzerland and Taiwan 4Q 2023 Update| Commercial Market 6 2023 GAAP financial summary Cash and investments: $13.3B 7 © 2024 Moderna, Inc. All rights reserved. 2023 Bus ...